Press releases
- Edwards Lifesciences Reports First Quarter Results
- Edwards Lifesciences to Host Earnings Conference Call on April 25, 2024
- Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease Without Knowing It
- Large, Real-world Studies Demonstrate Continued Excellent Outcomes for Patients Receiving Edwards SAPIEN TAVR
- Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference
- Edwards Lifesciences Reports Fourth Quarter Results
More ▼
Key statistics
On Monday, Edwards Lifesciences Corp (EWL:FRA) closed at 79.63, -10.45% below its 52-week high of 88.92, set on Mar 28, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 78.92 |
---|---|
High | 79.63 |
Low | 78.92 |
Bid | 78.63 |
Offer | 79.41 |
Previous close | 79.27 |
Average volume | 1.00k |
---|---|
Shares outstanding | 602.60m |
Free float | 597.24m |
P/E (TTM) | 36.64 |
Market cap | 51.37bn USD |
EPS (TTM) | 2.33 USD |
Data delayed at least 15 minutes, as of May 06 2024 09:20 BST.
More ▼